Cargando…

Immune Globulin Subcutaneous (Human) 20%: In Primary Immunodeficiency Disorders

Immune globulin subcutaneous 20% is a new high-concentration (200 g/L) solution of highly purified human IgG (≥98%) indicated in the EU and the US for antibody replacement therapy in patients with primary immunodeficiency with antibody deficiency, and in the EU for replacement therapy in humoral imm...

Descripción completa

Detalles Bibliográficos
Autor principal: McCormack, Paul L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582812/
https://www.ncbi.nlm.nih.gov/pubmed/22621695
http://dx.doi.org/10.2165/11209490-000000000-00000